Gene-edited pigs could be harvested for human organ transplants

The number of patients on transplant lists far outweighs the number of available organs, but a new development in gene editing could change things. Researchers have created gene-edited piglets without viruses that can cause diseases in humans. These animals could be harvested for their organs to be transplanted into human patients.

“They could be a real game changer,” said David Klassen, MD, CMO at the United Network for Organ Sharing, a private, nonprofit organization that manages the nation’s transplant system.

The organs could be used as liver, heart and other transplantations in the hopes that to reduce transplant waiting lists.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

While Kardium raised $250 million in an oversubscribed funding round, Field Medical raised $35 million. Both companies are focused on designing and developing new pulsed field ablation technologies to help treat challenging arrhythmias. 

Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.

Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.